The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II trial evaluating efficacy of neo-/adjuvant EIA CTX, surgery, and radiation therapy in high-risk soft tissue sarcoma.
T. Schmitt
No relevant relationships to disclose
B. Kasper
No relevant relationships to disclose
M. Bischof
No relevant relationships to disclose
B. Lehner
No relevant relationships to disclose
S. Dietrich
No relevant relationships to disclose
A. Dimitrakopoulou-Strauss
No relevant relationships to disclose
L. G. Strauss
No relevant relationships to disclose
G. Mechtersheimer
No relevant relationships to disclose
P. Wuchter
No relevant relationships to disclose
A. D. Ho
No relevant relationships to disclose
G. Egerer
No relevant relationships to disclose